To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Dual Compartment vs. Single Compartment Steroid Injection for de Quervain Disease

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2022

Dual Compartment vs. Single Compartment Steroid Injection for de Quervain Disease

Vol: 255| Issue: 3| Number:26| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Is a Steroid Injection in Both Compartments More Effective than an Injection in the Extensor Pollicis Brevis Subcompartment Alone in Patients with de Quervain Disease? A Randomized, Controlled Trial.

Clin Orthop Relat Res. 2022 Apr 1;480(4): 762-770.

Contributing Authors:
HS Jung SH Baek JS Lee

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

50 patients with de Quervain disease were randomized to receive a steroid injection into the extensor pollicis brevis subcompartment only (n=25) or into both the abductor pollicis longus and extensor pollicis brevis subcompartments (n=25). The outcomes of interest included pain on a Visual Analog Scale (VAS) and the incidence of injection-related complications. Results revealed no significant diff...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue